Molecular Templates, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Common Share (Tables)

Net Loss Per Common Share (Tables)

3 Months Ended

Mar. 31, 2014

Reconciliation of Numerator and Denominator

A reconciliation of the numerator and denominator used in the calculation is as follows (in thousands, except per share amounts):


	Three Months Ended March 31,
	2014			2013
Numerator:
Net loss-basic	$	(7,109	)	$	(9,214	)
Less: noncash income from change in fair value of common stock warrants		1,757			—

Net loss-diluted	$	(8,866	)	$	(9,214	)

Denominator:
Weighted average common shares outstanding		59,303			56,486
Dilutive effect of warrants		1,997			—

Weighted-average common shares outstanding and potential dilutive common shares — diluted		61,300			56,486

Net loss per share
Basic	$	(0.12	)	$	(0.16	)
Diluted	$	(0.14	)	$	(0.16	)

Warrants, Options and Purchase Rights Excluded from Computation of Diluted Net Loss Per Share

The following outstanding warrants, options and purchase rights under the Company’s 2004 Employee Stock Purchase Plan were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an antidilutive effect (in thousands):


	As of March 31,
	2014		2013
Shares issuable upon exercise of warrants		4,288		11,573
Shares issuable upon exercise of stock options		6,656		6,481
Shares issuable related to the ESPP		31		48